Search Results - "Isert, D"
-
1
Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin
Published in Antimicrobial Agents and Chemotherapy (01-01-1991)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
2
Comparative chemotherapeutic efficacy of balhimycin, desgluco-balhimycin against experimental MSSA and MRSA infection in mice
Published in Indian journal of experimental biology (01-07-2000)“…Balhimycin and desglucobalhimycin are glycopeptide antibiotics isolated from an Amycolatopsis spp during the search for novel antibacterials against MRSA from…”
Get full text
Journal Article -
3
Chemotherapeutic activity of levofloxacin (HR 355, DR-3355) against systemic and localized infections in laboratory animals
Published in Journal of antimicrobial chemotherapy (01-06-1995)“…Ofloxacin, its optical isomers levofloxacin (HR 355, DR-3355) and D-ofloxacin (DR-3354) and ciprofloxacin were administered orally to mice and rats which had…”
Get more information
Journal Article -
4
Transport theory for a scalar quark & gluon model
Published in The European physical journal. A, Hadrons and nuclei (01-12-2001)Get full text
Journal Article -
5
The in-vitro antibacterial activity of a combination of cefpirome or cefoperazone with vancomycin against enterococci and Staphylococcus aureus
Published in Journal of antimicrobial chemotherapy (1992)“…Cefpirome, cefoperazone and ceftazidime were tested for their in-vitro activity against Enterococcus faecalis and methicillin-resistant Staphylococcus aureus…”
Get more information
Journal Article -
6
Pharmacokinetics of cefpirome administered intravenously or intramuscularly to rats and dogs
Published in Journal of antimicrobial chemotherapy (01-04-1992)“…The pharmacokinetic profile of cefpirome was evaluated in rats and dogs after a single intravenous or intramuscular dose. A two-compartment open model was used…”
Get more information
Journal Article -
7
-
8
RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. I. Antibacterial activity in vitro
Published in Journal of antibiotics (1992)“…The aminothiazolyl-cephalosporin RU 29 246 is the active metabolite of the prodrug-pivaloyl-oxyethyl-ester HR 916. RU 29 246 in vitro activity includes a wide…”
Get more information
Journal Article -
9
Antibacterial activity in vitro of cefpirome against clinical isolates causing sexually transmitted diseases
Published in Journal of antimicrobial chemotherapy (1992)“…The in-vitro activity of cefpirome was compared with other antibiotics against organisms causing sexually transmitted diseases (STD). The excellent activity of…”
Get more information
Journal Article -
10
Comparative chemotherapeutic activity of cefpirome and imipenem in experimental infections
Published in Journal of antibiotics (01-01-1990)“…In systemic and local infections, the therapeutic efficacy of cefpirome was compared to that of imipenem and cefotaxime. Murine septicemia induced with…”
Get more information
Journal Article -
11
RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. II. Stability to beta-lactamases and affinity for penicillin-binding proteins
Published in Journal of antibiotics (1992)“…The aminothiazolyl-cephalosporin RU 29 246, the active metabolite of the prodrug-ester HR 916, is active against strains producing the widespread…”
Get more information
Journal Article -
12
RU 29 246, the active compound of the cephalosporin prodrug-ester HR 916. III. Pharmacokinetic properties and antibacterial activity in vivo
Published in Journal of antibiotics (1992)“…The pharmacokinetics of the broad spectrum cephem RU 29 246 and its prodrug-ester HR 916 B were investigated in mice, rats and dogs and compared to those of…”
Get more information
Journal Article -
13
HRE 664, a new parenteral penem. II. Evaluation of the pharmacokinetic behavior and the chemotherapeutic activity in animals
Published in Journal of antibiotics (1987)“…The pharmacokinetic and chemotherapeutic properties of the new penem antibiotic HRE 664 (Fig. 1) were evaluated in experimental animals. High and sustained…”
Get more information
Journal Article -
14
-
15
HRE 664, a new parenteral penem. I. Antibacterial activity in vitro
Published in Journal of antibiotics (1987)“…The new penem antibiotic HRE 664 displays potent antibacterial activity in vitro against a broad spectrum of clinically relevant bacterial strains including…”
Get more information
Journal Article -
16
The in vitro activity of the combination of cefotaxime and HRE 664
Published in Journal of antibiotics (1987)“…Cefotaxime (CTX) and HRE 664 (a novel penem antibiotic) possess complementary in vitro properties. Differences can be observed in their antibacterial spectra,…”
Get more information
Journal Article -
17
Comparative effects of cefpirome (HR 810) and other cephalosporins on experimentally induced pneumonia in mice
Published in Journal of antibiotics (1986)“…The chemotherapeutic efficacy of cefpirome (HR 810), a new polar aminothiazolylcephalosporin and that of ceftazidime, cefotaxime, cefoperazone, latamoxef and…”
Get more information
Journal Article -
18
Composite nasal septal graft reconstruction of the partial laryngectomized canine
Published in Otolaryngology (Rochester) (01-03-1978)“…Composite nasal septal grafts provide excellent autogenous replacement tissue for the partial laryngectomy defect. The added factor of a mucosa similar to that…”
Get more information
Journal Article -
19
Ustilipids, acylated beta-D-mannopyranosyl D-erythritols from Ustilago maydis and Geotrichum candidum
Published in Journal of antibiotics (01-02-2003)“…Ustilago species produce an extracellular oil that shows activity in various pharmaceutical assays. We isolated several complexes of this heterogeneous…”
Get more information
Journal Article -
20
Mulundocandin, an echinocandin-like lipopeptide antifungal agent: biological activities in vitro
Published in Journal of antibiotics (1999)“…Mulundocandin (MCN) is an antifungal lipopeptide which belongs to the echinocandin class of antimycotic agents. MCN exhibited good in vitro activity against…”
Get more information
Journal Article